Cancer Research Meeting Calendar Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamaguchi, H.
Right arrow Articles by Wang, H.-G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamaguchi, H.
Right arrow Articles by Wang, H.-G.
[Cancer Research 63, 1483-1489, April 1, 2003]
© 2003 American Association for Cancer Research

Epidemiology and Prevention

Bax Plays a Pivotal Role in Thapsigargin-induced Apoptosis of Human Colon Cancer HCT116 Cells by Controlling Smac/Diablo and Omi/HtrA2 Release from Mitochondria1

Hirohito Yamaguchi, Kapil Bhalla and Hong-Gang Wang2

Drug Discovery Program [H. Y., H-G. W.] and Clinical Investigations Program [K. B.], H. Lee Moffitt Cancer Center and Research Institute, and Department of Interdisciplinary Oncology, University of South Florida College of Medicine [H. Y., K. B., H-G. W.], Tampa, Florida 33612


   ABSTRACT
Top
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Bax is a crucial mediator of the mitochondrial pathway for apoptosis, and loss of this proapoptotic Bcl-2 family protein contributes to drug resistance in human cancers. We report here that the endoplasmic reticulum Ca2+-ATPase inhibitor thapsigargin (THG) induces apoptosis of human colon cancer HCT116 cells through a Bax-dependent signaling pathway controlling the cytosolic release of mitochondrial apoptogenic molecules. Treating HCT116 cells with THG results in caspase-8 activation; Bid cleavage; Bax conformational change and mitochondrial translocation; the release of cytochrome c, Smac/Diablo, and Omi/HtrA2 into the cytosol; caspase-3 activation; and apoptosis. In contrast, knockout of Bax completely abrogates the full processing/activation of caspase-3 but has no effect on the processing of caspase-8 and the initial cleavage of caspase-3 to p24 fragment after THG treatment. The caspase-8-specific inhibitor z-IETD-fmk, as well as pan-caspase inhibitor z-VAD-fmk, but not the calpain inhibitor E-64d, prevents Bid cleavage, Bax conformational change, and subsequent caspase-3 processing and apoptosis. Caspase-8 processing is dependent on de novo protein synthesis; DR5 expression is strongly up-regulated by THG treatment. Moreover, the absence of Bax blocks THG-induced Omi and Smac release from mitochondria, and expression of cytosolic Omi (GFP-IETD-Omi) or Smac (GFP-IETD-Smac) restores the sensitivity of Bax-knockout HCT116 cells to apoptosis in response to THG treatment. Taken together, our results indicate that Bax-dependent Smac and Omi release plays an essential role in caspase-3 activation and apoptosis induced by THG in human colon cancer HCT116 cells.


   INTRODUCTION
Top
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Apoptotic signal is regulated by an orchestrated cascade of cysteine proteases known as caspases whose activation can be mainly controlled by two distinct pathways, involving either death receptor (extrinsic) or mitochondria (intrinsic; Ref. 1 ). In the extrinsic pathway, stimulation of death receptors, such as Fas, tumor necrosis factor receptor 1, DR3, DR4, or DR5, with their cognate ligands leads to formation of a death-inducing signaling complex containing the death receptor, adapter proteins, such as Fas-associated death domain, and certain initiator caspases, such as pro-caspase-8 (2) . Consequently, pro-caspase-8 becomes activated by autoproteolytic processing, and the resulting active caspase-8 cleaves and activates downstream effector caspases, such as caspase-3, -6, and -7. In the mitochondrial pathway, a variety of death signals triggers the release of several pro-apoptotic proteins, such as cytochrome c, Smac/Diablo, Omi/HtrA2, apoptosis-inducing factor, and endonuclease G, from mitochondria to the cytosol or nucleus, where they are actively involved in the process of cell death (3) . Once released, e.g., cytochrome c forms a complex with Apaf-1 and pro-caspase-9 in the presence of dATP or ATP, resulting in processing and activation of this initiator caspase (4) . In contrast, Smac/Diablo or Omi/HtrA2 promotes caspase activation by direct binding to and inhibiting the IAP family caspase inhibitors (3 , 4) .

The Bcl-2 family of proteins plays a critical role in the mitochondrial pathway of apoptosis (1 , 5) . The antiapoptotic Bcl-2 family proteins like Bcl-2 and Bcl-XL possess four conserved domains (BH1, 2, 3, and 4) and inhibit the release of certain pro-apoptotic factors from mitochondria. In contrast, pro-apoptotic Bcl-2 family molecules, which can be further divided into two subgroups, BH3 only and multidomain BH1–3 proteins, induce the release of mitochondrial apoptogenic molecules into the cytosol. Genetic studies show that the multidomain pro-apoptotic proteins Bax and Bak are absolutely required for apoptosis induction by diverse intrinsic death stimuli (6) . Bak is a mitochondrial protein, whereas Bax is predominantly located in the cytoplasm of healthy cells (7) . Apoptotic signals induce a conformational change in the Bax protein, which is intimately associated with its mitochondrial integration and pro-apoptotic activity (8 , 9) . The BH3-only proteins, such as Bid and Bim, have been shown to activate the multidomain proapoptotic proteins for apoptosis induction (10, 11, 12) . However, the pro-apoptotic activities of BH3-only proteins are regulated by a variety of post-translational modifications, such as phosphorylation and proteolysis, or transcriptional control (1) .

THG3 is an inhibitor of the ER Ca2+-ATPase and induces proliferation-independent apoptosis in a variety of cell types (13, 14, 15, 16) . THG treatment elevates intracellular Ca2+ levels and induces ER stress by perturbation of Ca2+ levels in ER (13 , 17) . Elevation of intracellular Ca2+ activates several pro-apoptotic proteins, such as the protein phosphatase calcineurin and the Ca2+-dependent protease calpain. Calcineurin dephosphorylates and activates the BH3-only protein Bad (16 , 18, 19, 20) , whereas calpain is possibly involved in apoptosis by cleavage of caspase-12, XIAP, Bcl-XL, or Bid (21, 22, 23) . In addition, prolonged ER stress activates the ER transmembrane serine/threonine kinase IRE1, and the activated IRE1 in turn recruits TRAF2, which interacts with ASK1 or caspase-12, resulting in c-Jun-NH2-terminal kinase or caspase-12 activation (24 , 25) .

In the present study, we demonstrate that THG induces apoptosis of HCT116 cells by activating Bax through a caspase-8-dependent pathway, leading to the release of Smac and Omi into the cytosol to further amplify the caspase-8 signal for the full processing/activation of caspase-3 and apoptosis.


   MATERIALS AND METHODS
Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Reagents.
THG, staurosporine, etoposide, Taxol, E-64d, CHX, and anti-Bax 6A7 monoclonal antibody were purchased from Sigma. Epothilone B analogue (BMS-247550) was kindly provided by Bristol-Myers Squibb. Anti-Bax (N-20) polyclonal antibody was purchased from Santa Cruz Biotechnology. Anticaspase-3, caspase-7, and Bid polyclonal antibodies, as well as anticytochrome c monoclonal antibody, were purchased from BD PharMingen. Anti-COX IV monoclonal antibody was purchased from Molecular Probes. Anticaspase-8 monoclonal antibody and caspase inhibitors were purchased from Alexis. Anti-Bip polyclonal antibody was purchased from Stressgen Biotechnologies. Anti-Smac polyclonal antibody was purchased from Calbiochem. Anti-Omi antibody as well as pEGFP-IETD-Smac and pEGFP-IETD-Omi plasmids were kindly provided by Dr. Emad Alnemri (Kimmel Cancer Institute, Philadelphia, PA).

Cell Culture and Transfection.
HCT116 Bax+/- and Bax-/- cells were kindly provided by Dr. Bert Vogelstein (John Hopkins University, Baltimore, MD) and sustained in McCoy’s 5A medium, supplemented with 10% FCS and 1% penicillin/streptomycin. These cells were transfected with TransIT-LT-1 transfection reagent (Mirus) according to the manufacturer’s protocol.

Detection of DNA Fragmentation.
Cells (2 x 106) were cultured for the indicated periods with 1 µM THG and lysed in 100 µl of lysis buffer [10 mM Tris-HCl (pH 8.0), 10 mM EDTA, 0.5% Triton X-100, and 0.1 mg/ml RNase A]. After incubation for 1 h at 37°C, the lysate was further incubated for 30 min at 50°C in the presence of 0.2 mg/ml Protease K. Fragmented DNA was precipitated by adding 20 µl of 5 M NaCl and 120 µl of isopropanol, dissolved in 10 mM Tris-HCl (pH 8) and 1 mM EDTA, and electrophoresed on 1.5% agarose gel.

Caspase Activity Assay.
The caspase fluorescent assay kits specific for caspase-3 (Sigma) or caspase-9 (Clontech) were used to detect caspase activation by measuring for the cleavage of a synthetic fluorescent substrate. In brief, cells were cultured in 60-mm dishes and treated with 1 µM THG for the indicated periods. Cell lysates were prepared in lysis buffer from each assay kit, normalized for protein content by bicinchoninic acid assay kit (Pierce), and incubated for 1 h with a synthetic fluorescent substrate. After cleavage of the substrate by the caspase, fluorescence was measured by a fluorometer with excitation at 355 nm and emission at 460 nm.

Immunoprecipitation of Active Bax.
The detection of conformationally changed Bax was described previously (9 , 26) . Briefly, cell lysates were prepared in Chaps lysis buffer containing protease inhibitors, and 500 µg of total proteins were incubated with 2 µg of anti-Bax 6A7 antibody for 2 h at 4°C, followed by the addition of 20 µl of protein G agarose to precipitate the conformationally changed Bax protein. After extensive wash, the resulting immune complexes were subjected to immunoblot analysis with anti-Bax N20 polyclonal antibody.

Subcellular Fractionation.
Cells were lysed in mitochondria lysis buffer (12) with a Dounce homogenizer and subjected to centrifugation at 1,000 x g to pellet nuclei. The postnuclear supernatant was centrifuged at 10,000 x g to pellet mitochondria-enriched heavy membrane fraction, and the resulting supernatant was further centrifuged at 100,000 x g to obtain cytosolic fraction. Total proteins (50 µg) from each fraction were subjected to immunoblot analysis.

Immunofluorescence Analysis.
Cells were grown on coverslips and treated with or without 1 µM THG for 30 h. After incubation with 25 nM MitoTracker CMTMRos (Molecular Probes) for 30 min, cells were fixed with 3.7% formaldehyde for 5 min and permeabilized with 0.5% Triton X-100 in PBS for 3 min. After 30-min blocking with 3% BSA, cells were incubated with anti-Smac (1:200) or anti-Omi (1:500) for 2 h at 37°C, followed by incubation at 37°C for 1 h with FITC-conjugated secondary antibody. The coverslips were then mounted with DAPI-containing mount media (Vector Laboratories, Inc.) and analyzed by fluorescence microscopy.


   RESULTS
Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Bax Is Required for THG-induced Caspase-3 Activation and Apoptosis.
To determine the involvement of Bax in apoptosis induced by a variety of cytotoxic agents, we used HCT116 human colon cancer cells with one allele of bax gene (Bax+/-) versus Bax knockout HCT116 (Bax-/-) cells in which bax gene was inactivated by homologous recombination (27) . These cells were exposed to DNA damage (etoposide), ER stress (THG), microtubule damage (Taxol and epothilone B), or mitochondrial stress (staurosporine) for different periods, and cell viability was determined by trypan blue exclusion assay. As shown in Fig. 1ACitation , the deficiency of Bax affected cell death most remarkably in response to ER stress caused by the ER Ca2+-ATPase inhibitor THG. The requirement of Bax for THG-induced cell death in HCT116 cells was confirmed by extending the treatment with 1 µM THG <= 72 h (Fig. 1B)Citation . In both Bax+/- and Bax-/- cells, the protein level of Bip/GRP78, a molecular chaperon elevated in response to ER stress, was induced by THG treatment at 24 h, indicating that ER stress occurs independently of Bax (Fig. 1D)Citation . However, DNA fragmentation (one of the characteristics of apoptosis) was observed only in Bax+/- cells after THG treatment (Fig. 1C)Citation . Moreover, caspase-3 was processed to active forms (p20/17) in Bax+/- cells, but it was not fully processed and presented as an inactive p24 form (28) in Bax-/- cells (Fig. 1D)Citation . These results indicate that THG-induced full processing of caspase-3 and apoptosis in HCT116 cells are Bax dependent, but the initial processing of caspase-3 does not require the presence of Bax.



View larger version (51K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 1. THG induces Bax-dependent caspase-3 processing and apoptosis. In A, HCT116 Bax+/- and Bax-/- cells were treated with 25 µg/ml etoposide (VP16), 2 µM THG, 100 nM Taxol (Tax), 100 nM epothilone B analogue BMS-247550 (Epo), or 1 µM staurosporine (STS) for the indicated periods. Cell viability was evaluated by trypan blue dye exclusion assay. In B–D, HCT116 Bax+/- and Bax-/- cells were treated with 1 µM THG for various times and subjected to trypan blue dye exclusion assay (B), DNA fragmentation assay (C), or immunoblot analysis with anti-Bip/Grp78, caspase-3, or {alpha}-tubulin antibodies (D). Notably, in Bax-/- cells the p24 form of caspase-3 decreased and high molecular weight forms (asterisks) increased simultaneously after 48 h of THG treatment (D), implicating oligomerization of the p24 caspase-3 fragments.

 
It has been shown that apoptotic stimuli trigger Bax conformational change and translocation to mitochondria where active Bax causes cytochrome c release for subsequent activation of caspase-9 and certain downstream effector caspases (29) . To examine Bax activation in response to THG treatment, we performed immunoprecipitation experiments with anti-Bax 6A7 antibody that recognizes only the conformationally changed Bax protein. As shown in Fig. 2ACitation , Bax underwent a conformational change at ~12 h (Fig. 2A)Citation , preceding the full processing of caspase-3 and –7, which was detectable ~24 h after THG treatment (Fig. 2C)Citation . Subcellular fractionation/immunoblot analysis confirmed Bax translocation to mitochondria and cytochrome c release in Bax+/- cells treated with THG (Fig. 2B)Citation . Moreover, caspase activity assays revealed that caspase-3 and -9-like activities began to increase at 12 h after THG treatment in Bax+/- cells (Fig. 2D)Citation . In contrast, THG failed to induce cytochrome c release and activation of caspase-3, -7, and -9 in Bax knockout HCT116 cells (Fig. 2, B–D)Citation .



View larger version (42K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 2. THG triggers Bax conformational change and translocation to mitochondria for cytochrome c release and caspase activation. HCT116 Bax+/- or Bax-/- cells were treated with 1 µM THG for the indicated periods and subjected to the following assays. In A, Bax conformational change was detected by immunoprecipitation with anti-Bax 6A7 antibody. In B, mitochondrial translocation of Bax and cytochrome c release were assessed by subcellular fractionation/immunoblot analysis with antibodies specific for Bax, cytochrome c (Cyt C), or cytochrome c oxidase complex IV (COX IV). In C, the proteolytic processing of caspase-3 and -7 was examined by immunoblot analysis with antibodies specific for caspase-3 or -7. In D, caspase-3 and -9-like activities were determined by using synthetic fluorescent substrates DEVD-AMC or LEHD-AMC, respectively.

 
Caspase-8 but not Calpain Is Involved in THG-induced Bax Activation, Caspase-3 Processing, and Apoptosis.
THG has been reported to activate calpain that subsequently activates ER-localized caspase-12 or other caspases in cells (21) . Calpain also cleaves the BH3-only protein Bid, which in turn causes mitochondrial dysfunction and cytochrome c release (22 , 30) . To determine whether calpain is involved in THG-induced Bax conformational change and caspase-3 processing, we treated HCT116 cells with 1 µM THG in the presence of 20 µM calpain inhibitor E-64d, 50 µM pan-caspase inhibitor z-VAD-fmk, or DMSO as control. Immunoprecipitation with anti-Bax 6A7 antibody showed that z-VAD-fmk but not E-64d blocked Bax conformational change (Fig. 3B)Citation , indicating that caspase but not calpain is involved in THG-induced Bax activation. Similarly, blockade of calpain activity had no effect on the proteolytic processing of caspase-3 after THG treatment (Fig. 3A)Citation .



View larger version (19K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 3. Caspase inhibitor z-VAD-fmk but not calpain inhibitor E-64d prevents THG-induced Bax conformational change and caspase-3 processing. HCT116 Bax+/- and Bax-/- cells were treated with 1 µM THG in the presence of z-VAD-fmk (50 µM), E-64d (20 µM), or DMSO for the indicated periods and subjected to the following assays. In A, caspase-3 processing was examined by immunoblot analysis with anticaspase-3 polyclonal antibody. In B, Bax conformational change was assessed by immunoprecipitation with anti-Bax 6A7 monoclonal antibody.

 
To identify the caspase involved in the initiation of THG-induced apoptosis, we treated HCT116 cells with a variety of caspase inhibitors and subjected them to an analysis of cell viability and caspase-3 processing. Among the specific inhibitors, treating cells with caspase-8 inhibitor distinguishably prevented THG-induced cell death (Fig. 4A)Citation and processing of caspase-3 (Fig. 4B)Citation . In contrast, caspase-9 inhibitor had a little effect on THG-induced cell death (Fig. 4A)Citation and caspase-3 activation (Fig. 4B)Citation , suggesting that THG induces apoptosis via a caspase-8-dependent but cytochrome c/Apaf-1/caspase-9 (apoptosome)-independent pathway in HCT116 cells.



View larger version (38K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 4. Caspase-8 is the initiator caspase for THG-induced Bax conformational change and apoptosis. In A and B, HCT116 Bax+/- cells were treated with 1 µM THG in the presence of the indicated caspase inhibitors (10 µM) for 30 h and subjected to trypan blue exclusion assay (A) and immunoblot analysis (B) with anticaspase-3 antibody. In C, HCT116 Bax+/- and Bax-/- cells were treated with 1 µM THG for the indicated times before immunoblot analysis with anticaspase-8 or anti-Bid antibodies. In D, HCT116 Bax+/- cells were exposed to 1 µM THG with or without 20 µM caspase-8 inhibitor (z-IETD-fmk) for 30 h and subjected to immunoprecipitation with anti-Bax 6A7 antibody to determine Bax conformational change as well as immunoblot analysis with antibodies specific for caspase-8, Bid, or {alpha}-tubulin. In E, HCT116 Bax+/- cells were treated with 1 µM THG together with either 20 µM z-VAD-fmk, 20 µM z-IETD-fmk, or DMSO as control for various times and subjected to trypan blue dye exclusion assay. Half of the medium was replaced every day with fresh medium containing the indicated drugs.

 
It has been reported that the BH3-only protein Bid is a substrate of caspase-8 (31 , 32) and that the tBid can trigger Bax and Bak activation (10 , 33) . As shown in Fig. 4CCitation , THG-induced caspase-8 activation and Bid proteolysis could occur independently of Bax in HCT116 cells. However, treating cells with z-IETD-fmk (a specific inhibitor of caspase-8) blocked Bid cleavage (Fig. 4D)Citation , Bax conformational change (Fig. 4D)Citation , and apoptosis (Fig. 4E)Citation , indicating that caspase-8 is the initiator caspase responsible for THG-induced Bax activation and apoptosis in HCT116 cells.

To examine whether THG-induced caspase activation requires new protein synthesis, HCT116 cells were exposed to 1 µM THG in the presence or absence of 50 µg/ml CHX for 24 h and subjected to immunoblot analysis with anticaspase-8 or caspase-3 antibody. As shown in Fig. 5ACitation , both caspase-8 and -3 processing were completely inhibited in the presence of CHX, suggesting that de novo protein synthesis is involved in THG-induced apoptosis of HCT116 cells. Moreover, it has been reported recently that THG induces DR5 expression in several cancer cells (34) . Thus, we examined DR5 expression in HCT116 Bax+/- and Bax-/- cells in response to THG treatment. As shown in Fig. 5BCitation , DR5 was strongly induced by THG treatment, suggesting a possibility that THG induces Bax activation and apoptosis through DR5-mediated caspase-8 activation.



View larger version (60K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 5. THG-induced caspase activation requires de novo protein synthesis, and THG up-regulates DR5 expression in HCT116 cells. In A, HCT116 Bax+/- and Bax-/- cells were treated with 1 µM THG in the presence (+) or absence (-) of 50 µg/ml CHX for 24 h. Caspase processing was assessed by immunoblot analysis with anticaspase-3 or -8 antibodies. In B, HCT116 Bax+/- and Bax-/- cells were exposed to 1 µM THG for various times before immunoblot analysis with anti-DR5 antibody.

 
Bax-dependent Smac and Omi Release from Mitochondria Is Essential for THG-induced Cell Death.
It has been shown that caspase-8 cleaves pro-caspase-3 to produce the p12 small subunit and a p24 intermediate that undergoes autoproteolytic processing to generate the p20/p17 forms of the large subunit and that the IAP family proteins inhibit this process (28 , 35) . Early during apoptosis, Smac/Diablo and Omi/HtrA2 are released from mitochondria into the cytosol where they bind to and inhibit the IAP family proteins (3) . To investigate whether the release of Smac and Omi from mitochondria is dependent of Bax, we performed immunofluorescence analysis with specific antibodies for Smac or Omi in HCT116 Bax+/- versus Bax-/- cells treated with or without 1 µM THG for 30 h. As shown in Fig. 6ACitation , both Smac and Omi colocalized with mitochondria in control DMSO-treated cells. In contrast, THG treatment resulted in a diffuse distribution of Smac and Omi in Bax+/- but not Bax-/- cells, indicating that THG-induced Smac and Omi release requires the presence of Bax.



View larger version (65K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 6. Bax-mediated Smac and Omi release plays an essential role in THG-induced apoptosis. In A, HCT116 Bax+/- or Bax-/- cells were treated with 1 µM THG for 30 h and stained with anti-Smac or Omi antibodies followed by FITC-conjugated secondary antibody. Nuclei and mitochondria were stained with DAPI and MitoTracker, respectively. In B, HCT116 Bax-/- cells were transfected with pEGFP-IETD-Smac or pEGFP-IETD-Omi plasmid DNA for 24 h and treated with 1 µM THG or DMSO for an additional 24 h. Cells were fixed with 3.7% formaldehyde, stained with DAPI, and analyzed by fluorescence microscopy. In C, cells with fragmented or condensed DNA in B were counted as apoptosis (mean ± SD; n = 3). D, a model of THG-induced apoptosis.

 
To determine whether Bax-mediated Smac and/or Omi release is critical for THG-induced apoptosis, we transfected Bax-/- HCT116 cells with either GFP-IETD-Smac or GFP-IETD-Omi expression plasmids to produce cytosolic mature Smac or Omi after caspase-8 cleavage (36 , 37) . As shown in Fig. 6, B and CCitation , overexpression of cytosolic Smac or Omi restored the sensitivity of Bax-null HCT116 cells to apoptosis induced by THG treatment.


   DISCUSSION
Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
Loss of the pro-apoptotic multidomain Bcl-2 family member Bax contributes to drug resistance in cancer (27) . Bax can be activated by a variety of death signals (6) , but it seems to be cell type dependent. THG is an inhibitor of Ca2+-ATPase of the ER and induces proliferation-independent apoptosis in a variety of cell types. THG analogues coupled with a synthetic peptide specifically cleaved by prostate-specific antigen have been developed recently (38) . This promising prodrug can be targeted to specific cancer for induction of apoptosis. The precise biochemical mechanisms by which THG induces apoptosis of cancer cells, however, are still unclear, although several theories have been advanced, including regulation of calcineurin, calpain, caspase-12, ASK1, transglutaminase, and Gadd153 (21 , 24 , 39, 40, 41, 42) .

In the present study, we showed that THG up-regulates DR5 expression and triggers caspase-8 activation independently of Bax in human colon cancer HCT116 cells. Moreover, de novo protein synthesis is required for the processing and activation of this initiator caspase, which is particularly involved in the death receptor-mediated pathway for apoptosis, suggesting that up-regulation of DR5 could be the mechanism for THG-induced caspase-8 activation in HCT116 cells. In support of this model, recent evidence provided by He et al. (34) indicates that ER stress indeed induces apoptosis through activation of the DR5 pathway.

In most of cancer cells, caspase-8 activation cannot achieve the full processing of caspase-3; thus, the apoptotic signal needs to be amplified through a mitochondrial pathway (4) . The BH3-only proapoptotic protein Bid undergoes proteolysis by caspase-8 during apoptosis, and the resulting tBid contributes to amplification of the apoptotic signal from death receptors by activating Bax. Consistently, our results show that inhibition of caspase-8 activity blocks Bid proteolysis and Bax conformational change induced by THG treatment (Fig. 4D)Citation . Although Bax is not required for THG-induced caspase-8 activation and Bid cleavage, it plays an important role in the release of apoptogenic molecules, such as cytochrome c, Smac/Diablo, and Omi/HtrA2, from mitochondria induced by THG in HCT116 cells (Figs. 2BCitation and 6ACitation ). However, caspase-9 activity is not essential for THG-induced caspase-3 activation and apoptosis of HCT116 cells (Fig. 4, A and B)Citation , implying the importance of other mitochondrial molecules besides cytochrome c for achieving the full caspase-3 processing and apoptosis induction by ER stress.

It has been shown that Smac/Diablo and Omi/HtrA2 promote the processing and activation of caspase-3 by antagonizing the IAP family proteins once released from mitochondria (3) . Moreover, transfecting cells with cytosolic Smac or Omi expression plasmids or synthetic Smac peptide sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis (36 , 37 , 43, 44, 45) . We found that overexpression of GFP-IETD-Smac or GFP-IETD-Omi, which is converted to mature cytosolic Smac or Omi after caspase-8 cleavage, restored the sensitivity of Bax-knockout HCT116 cells to apoptosis after THG treatment (Fig. 6, B and C)Citation . Compared with Smac, Omi is more potent to induce cell death of HCT116 cells (Fig. 6, B and C)Citation , probably because of its serine protease activity (37 , 46) . These findings strongly argue that Bax-dependent release of Smac and/or Omi plays a critical role in ER stress-induced apoptosis.

Taken together, our findings reported here suggest a possible pathway for ER stress-mediated apoptosis in human colon cancer cells (Fig. 6D)Citation . In response to THG treatment, caspase-8 becomes activated through the death receptor, such as DR5 pathway, to trigger the initial processing of caspase-3/7. However, the full processing/activation of these executor caspases is blocked by the IAP family proteins. To achieve apoptosis, caspase-8 cleaves the BH3-only protein Bid to generate active tBid that induces Bax conformational change and translocation to mitochondria, causing the release of apoptogenic molecules, such as Smac and Omi, into the cytosol, where they antagonize the IAP family proteins. Therefore, the efforts to manipulate the activity of Bcl-2 family or IAP family proteins in malignant cells may one day become an important part of the armamentarium used to destroy chemoresistant cancer cells.


   ACKNOWLEDGMENTS
 
We thank Dr. Bert Vogelstein (Johns Hopkins Medical School) for the gift of HCT116 Bax+/- and Bax-/- cells and Dr. Emad Alnemri (Kimmel Cancer Institute) for kindly providing pEGFP-IETD-Smac and pEGFP-IETD-Omi plasmids and anti-Omi antibody.


   FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported by NIH Grant CA82197. H. Y. is a fellow of the Lymphoma Research Foundation. Back

2 To whom requests for reprints should be addressed, at Drug Discovery Program, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, Florida 33612. Back

3 The abbreviations used are: THG, thapsigargin; ER, endoplasmic reticulum; CHX, cycloheximide; DAPI, 4',6-diamidino-2-phenylindole; DR5, death receptor 5; IAP, inhibitor of apoptosis protein; GFP, green fluorescence protein; tBid, truncated Bid. Back

Received 10/29/02. Accepted 2/ 3/03.


   REFERENCES
Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Reed J. C. Apoptosis-regulating proteins as targets for drug discovery. Trends Mol. Med., 7: 314-319, 2001.[Medline]
  2. Ashkenazi A., Dixit V. M. Death receptors: signaling and modulation. Science (Wash. DC), 281: 1305-1308, 1998.[Abstract/Free Full Text]
  3. Van Loo G., Saelens X., Van Gurp M., MacFarlane M., Martin S. J., Vandenabeele P. The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ., 9: 1031-1042, 2002.[Medline]
  4. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev., 15: 2922-2933, 2001.[Free Full Text]
  5. Wang H-G., Reed J. C. Mechanisms of Bcl-2 protein function. Histol. Histopathol., 13: 521-530, 1998.[Medline]
  6. Wei M. C., Zong W. X., Cheng E. H., Lindsten T., Panoutsakopoulou V., Ross A. J., Roth K. A., MacGregor G. R., Thompson C. B., Korsmeyer S. J. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science (Wash. DC), 292: 727-730, 2001.[Abstract/Free Full Text]
  7. Nechushtan A., Smith C. L., Lamensdorf I., Yoon S. H., Youle R. J. Bax and Bak coalesce into novel mitochondria-associated clusters during apoptosis. J. Cell Biol., 153: 1265-1276, 2001.[Abstract/Free Full Text]
  8. Wolter K. G., Hsu Y. T., Smith C. L., Nechushtan A., Xi X. G., Youle R. J. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol., 139: 1281-1292, 1997.[Abstract/Free Full Text]
  9. Yamaguchi H., Paranawithana S. R., Lee M. W., Huang Z., Bhalla K. N., Wang H-G. Epothilone B analogue (BMS-247550)-mediated cytotoxicity through induction of Bax conformational change in human breast cancer cells. Cancer Res., 62: 466-471, 2002.[Abstract/Free Full Text]
  10. Eskes R., Desagher S., Antonsson B., Martinou J. C. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol. Cell. Biol., 20: 929-935, 2000.[Abstract/Free Full Text]
  11. Marani M., Tenev T., Hancock D., Downward J., Lemoine N. R. Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis. Mol. Cell. Biol., 22: 3577-3589, 2002.[Abstract/Free Full Text]
  12. Yamaguchi H., Wang H-G. Bcl-XL protects BimEL-induced Bax conformational change and cytochrome c release independent of interacting with Bax or BimEL. J. Biol. Chem., 277: 41604-41612, 2002.[Abstract/Free Full Text]
  13. Furuya Y., Lundmo P., Short A., Gill D., Isaacs J. The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin. Cancer Res., 54: 6167-6175, 1994.[Abstract/Free Full Text]
  14. Muthukkumar S., Nair P., Sells S. F., Maddiwar N. G., Jacob R. J., Rangnekar V. M. Role of EGR-1 in thapsigargin-inducible apoptosis in the melanoma cell line A375–C6. Mol. Cell. Biol., 15: 6262-6272, 1995.[Abstract]
  15. Qi X. M., He H., Zhong H., Distelhorst C. W. Baculovirus p35 and Z-VAD-fmk inhibit thapsigargin-induced apoptosis of breast cancer cells. Oncogene, 15: 1207-1212, 1997.[Medline]
  16. Wang H-G., Pathan N., Ethell I. M., Krajewski S., Yamaguchi Y., Shibasaki F., McKeon F., Bobo T., Franke T., Reed J. C. Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science (Wash. DC), 284: 339-343, 1999.[Abstract/Free Full Text]
  17. Ferri K. F., Kroemer G. Organelle-specific initiation of cell death pathways. Nat. Cell Biol., 3: E255-E263, 2001.[Medline]
  18. Saito S., Hiroi Y., Zou Y., Aikawa R., Toko H., Shibasaki F., Yazaki Y., Nagai R., Komuro I. ß-Adrenergic pathway induces apoptosis through calcineurin activation in cardiac myocytes. J. Biol. Chem., 275: 34528-34533, 2000.[Abstract/Free Full Text]
  19. Springer J. E., Azbill R. D., Nottingham S. A., Kennedy S. E. Calcineurin-mediated BAD dephosphorylation activates the caspase-3 apoptotic cascade in traumatic spinal cord injury. J. Neurosci., 20: 7246-7251, 2000.[Abstract/Free Full Text]
  20. Tombal B., Weeraratna A. T., Denmeade S. R., Isaacs J. T. Thapsigargin induces a calmodulin/calcineurin-dependent apoptotic cascade responsible for the death of prostatic cancer cells. Prostate, 43: 303-317, 2000.[Medline]
  21. Nakagawa T., Yuan J. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J. Cell Biol., 150: 887-894, 2000.[Abstract/Free Full Text]
  22. Mandic A., Viktorsson K., Strandberg L., Heiden T., Hansson J., Linder S., Shoshan M. C. Calpain-mediated Bid cleavage and calpain-independent Bak modulation: two separate pathways in cisplatin-induced apoptosis. Mol. Cell. Biol., 22: 3003-3013, 2002.[Abstract/Free Full Text]
  23. Kobayashi S., Yamashita K., Takeoka T., Ohtsuki T., Suzuki Y., Takahashi R., Yamamoto K., Kaufmann S. H., Uchiyama T., Sasada M., Takahashi A. Calpain-mediated X-linked inhibitor of apoptosis degradation in neutrophil apoptosis and its impairment in chronic neutrophilic leukemia. J. Biol. Chem., 277: 33968-33977, 2002.[Abstract/Free Full Text]
  24. Nishitoh H., Matsuzawa A., Tobiume K., Saegusa K., Takeda K., Inoue K., Hori S., Kakizuka A., Ichijo H. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev., 16: 1345-1355, 2002.[Abstract/Free Full Text]
  25. Yoneda T., Imaizumi K., Oono K., Yui D., Gomi F., Katayama T., Tohyama M. Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress. J. Biol. Chem., 276: 13935-13940, 2001.[Abstract/Free Full Text]
  26. Yamaguchi H., Wang H-G. The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene, 20: 7779-7786, 2001.[Medline]
  27. Zhang L., Yu J., Park B. H., Kinzler K. W., Vogelstein B. Role of BAX in the apoptotic response to anticancer agents. Science (Wash. DC), 290: 989-992, 2000.[Abstract/Free Full Text]
  28. Deveraux Q. L., Roy N., Stennicke H. R., Van Arsdale T., Zhou Q., Srinivasula S. M., Alnemri E. S., Salvesen G. S., Reed J. C. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J., 17: 2215-2223, 1998.[Medline]
  29. Rathmell J. C., Thompson C. B. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell, 109: S97-S107, 2002.
  30. Chen M., He H., Zhan S., Krajewski S., Reed J. C., Gottlieb R. A. Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/reperfusion. J. Biol. Chem., 276: 30724-30728, 2001.[Abstract/Free Full Text]
  31. Luo X., Budihardjo I., Zou H., Slaughter C., Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell, 94: 481-490, 1998.[Medline]
  32. Li H., Zhu H., Xu C. J., Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell, 94: 491-501, 1998.[Medline]
  33. Wei M. C., Lindsten T., Mootha V. K., Weiler S., Gross A., Ashiya M., Thompson C. B., Korsmeyer S. J. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev., 14: 2060-2071, 2000.[Abstract/Free Full Text]
  34. He Q., Lee D. I., Rong R., Yu M., Luo X., Klein M., El-Deiry W. S., Huang Y., Hussain A., Sheikh M. S. Endoplasmic reticulum calcium pool depletion-induced apoptosis is coupled with activation of the death receptor 5 pathway. Oncogene, 21: 2623-2633, 2002.[Medline]
  35. Fernandes-Alnemri T., Armstrong R. C., Krebs J., Srinivasula S. M., Wang L., Bullrich F., Fritz L. C., Trapani J. A., Croce C. M., Tomaselli K. J., Litwack G., Alnemri E. S. Activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA, 93: 7464-7469, 1996.[Abstract/Free Full Text]
  36. Srinivasula S. M., Datta P., Fan X. J., Fernandes-Alnemri T., Huang Z., Alnemri E. S. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway. J. Biol. Chem., 275: 36152-36157, 2000.[Abstract/Free Full Text]
  37. Hegde R., Srinivasula S. M., Zhang Z., Wassell R., Mukattash R., Cilenti L., DuBois G., Lazebnik Y., Zervos A. S., Fernandes-Alnemri T., Alnemri E. S. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J. Biol. Chem., 277: 432-438, 2002.[Abstract/Free Full Text]
  38. Jakobsen C. M., Denmeade S. R., Isaacs J. T., Gady A., Olsen C. E., Christensen S. B. Design, synthesis, and pharmacological evaluation of thapsigargin analogues for targeting apoptosis to prostatic cancer cells. J. Med. Chem., 44: 4696-4703, 2001.[Medline]
  39. Shibasaki F., Hallin U., Uchino H. Calcineurin as a multifunctional regulator. J. Biochem. (Tokyo), 131: 1-15, 2002.[Abstract/Free Full Text]
  40. Squier M. K., Miller A. C., Malkinson A. M., Cohen J. J. Calpain activation in apoptosis. J. Cell. Physiol., 159: 229-237, 1994.[Medline]
  41. Chen J. S., Mehta K. Tissue transglutaminase: an enzyme with a split personality. Int. J. Biochem. Cell Biol., 31: 817-836, 1999.[Medline]
  42. Tombal B., Denmeade S. R., Gillis J. M., Isaacs J. T. A supramicromolar elevation of intracellular free calcium ([Ca2+]i) is consistently required to induce the execution phase of apoptosis. Cell Death Differ., 9: 561-573, 2002.[Medline]
  43. Deng Y., Lin Y., Wu X. TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev., 16: 33-45, 2002.[Abstract/Free Full Text]
  44. Guo F., Nimmanapalli R., Paranawithana S., Wittman S., Griffin D., Bali P., O’Bryan E., Fumero C., Wang H. G., Bhalla K. Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo- 2L/TRAIL-induced apoptosis. Blood, 99: 3419-3426, 2002.[Abstract/Free Full Text]
  45. Fulda S., Wick W., Weller M., Debatin K. M. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat. Med., 8: 808-815, 2002.[Medline]
  46. Suzuki Y., Imai Y., Nakayama H., Takahashi K., Takio K., Takahashi R. A serine protease. HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol. Cell, 8: 613-621, 2001.[Medline]



This article has been cited by other articles:


Home page
 Mol. Biol. CellHome page
C.-Y. Wang, Y.-S. Lin, W.-C. Su, C.-L. Chen, and C.-F. Lin
Glycogen Synthase Kinase-3 and Omi/HtrA2 Induce Annexin A2 Cleavage followed by Cell Cycle Inhibition and Apoptosis
Mol. Biol. Cell, October 1, 2009; 20(19): 4153 - 4161.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Zhang, C. Lu, M. Whiteman, B. Chance, and J. S. Armstrong
The Mitochondrial Permeability Transition Regulates Cytochrome c Release for Apoptosis during Endoplasmic Reticulum Stress by Remodeling the Cristae Junction
J. Biol. Chem., February 8, 2008; 283(6): 3476 - 3486.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Shankar and R. K. Srivastava
Bax and Bak genes are essential for maximum apoptotic response by curcumin, a polyphenolic compound and cancer chemopreventive agent derived from turmeric, Curcuma longa
Carcinogenesis, June 1, 2007; 28(6): 1277 - 1286.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. R. Hussain, N. A. Al-Jomah, A. K. Siraj, P. Manogaran, K. Al-Hussein, J. Abubaker, L. C. Platanias, K. S. Al-Kuraya, and S. Uddin
Sanguinarine-Dependent Induction of Apoptosis in Primary Effusion Lymphoma Cells
Cancer Res., April 15, 2007; 67(8): 3888 - 3897.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
Y.-M. Ham, J.-H. Lim, H.-K. Na, J.-S. Choi, B.-D. Park, H. Yim, and S.-K. Lee
Ginsenoside-Rh2-Induced Mitochondrial Depolarization and Apoptosis Are Associated with Reactive Oxygen Species- and Ca2+-Mediated c-Jun NH2-Terminal Kinase 1 Activation in HeLa Cells
J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1276 - 1285.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. M. Fribley, B. Evenchik, Q. Zeng, B. K. Park, J. Y. Guan, H. Zhang, T. J. Hale, M. S. Soengas, R. J. Kaufman, and C.-Y. Wang
Proteasome Inhibitor PS-341 Induces Apoptosis in Cisplatin-resistant Squamous Cell Carcinoma Cells by Induction of Noxa
J. Biol. Chem., October 20, 2006; 281(42): 31440 - 31447.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
H. Yamaguchi and H.-G. Wang
Tissue Transglutaminase Serves as an Inhibitor of Apoptosis by Cross-Linking Caspase 3 in Thapsigargin-Treated Cells
Mol. Cell. Biol., January 15, 2006; 26(2): 569 - 579.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. Guo, K. Rocha, P. Bali, M. Pranpat, W. Fiskus, S. Boyapalle, S. Kumaraswamy, M. Balasis, B. Greedy, E. S. M. Armitage, et al.
Abrogation of Heat Shock Protein 70 Induction as a Strategy to Increase Antileukemia Activity of Heat Shock Protein 90 Inhibitor 17-Allylamino-Demethoxy Geldanamycin
Cancer Res., November 15, 2005; 65(22): 10536 - 10544.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
Y. Takahashi, M. Karbowski, H. Yamaguchi, A. Kazi, J. Wu, S. M. Sebti, R. J. Youle, and H.-G. Wang
Loss of Bif-1 Suppresses Bax/Bak Conformational Change and Mitochondrial Apoptosis
Mol. Cell. Biol., November 1, 2005; 25(21): 9369 - 9382.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. A. Obeng and L. H. Boise
Caspase-12 and Caspase-4 Are Not Required for Caspase-dependent Endoplasmic Reticulum Stress-induced Apoptosis
J. Biol. Chem., August 19, 2005; 280(33): 29578 - 29587.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Chandra, G. Choy, P. T. Daniel, and D. G. Tang
Bax-dependent Regulation of Bak by Voltage-dependent Anion Channel 2
J. Biol. Chem., May 13, 2005; 280(19): 19051 - 19061.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Zi and A. R. Simoneau
Flavokawain A, a Novel Chalcone from Kava Extract, Induces Apoptosis in Bladder Cancer Cells by Involvement of Bax Protein-Dependent and Mitochondria-Dependent Apoptotic Pathway and Suppresses Tumor Growth in Mice
Cancer Res., April 15, 2005; 65(8): 3479 - 3486.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
R. Rashmi, S. Kumar, and D. Karunagaran
Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL
Carcinogenesis, April 1, 2005; 26(4): 713 - 723.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. Rahmani, E. Reese, Y. Dai, C. Bauer, L. B. Kramer, M. Huang, R. Jove, P. Dent, and S. Grant
Cotreatment with Suberanoylanilide Hydroxamic Acid and 17-Allylamino 17-demethoxygeldanamycin Synergistically Induces Apoptosis in Bcr-Abl+ Cells Sensitive and Resistant to STI571 (Imatinib Mesylate) in Association with Down-Regulation of Bcr-Abl, Abrogation of Signal Transducer and Activator of Transcription 5 Activity, and Bax Conformational Change
Mol. Pharmacol., April 1, 2005; 67(4): 1166 - 1176.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Q. Gu, J. D. Wang, H. H.X. Xia, M. C.M. Lin, H. He, B. Zou, S. P. Tu, Y. Yang, X. G. Liu, S. K. Lam, et al.
Activation of the caspase-8/Bid and Bax pathways in aspirin-induced apoptosis in gastric cancer
Carcinogenesis, March 1, 2005; 26(3): 541 - 546.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. Yao, T.-V. V. Nguyen, and C. J. Pike
{beta}-Amyloid-Induced Neuronal Apoptosis Involves c-Jun N-Terminal Kinase-Dependent Downregulation of Bcl-w
J. Neurosci., February 2, 2005; 25(5): 1149 - 1158.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
F. Guo, C. Sigua, P. Bali, P. George, W. Fiskus, A. Scuto, S. Annavarapu, A. Mouttaki, G. Sondarva, S. Wei, et al.
Mechanistic role of heat shock protein 70 in Bcr-Abl-mediated resistance to apoptosis in human acute leukemia cells
Blood, February 1, 2005; 105(3): 1246 - 1255.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
A. Fribley, Q. Zeng, and C.-Y. Wang
Proteasome Inhibitor PS-341 Induces Apoptosis through Induction of Endoplasmic Reticulum Stress-Reactive Oxygen Species in Head and Neck Squamous Cell Carcinoma Cells
Mol. Cell. Biol., November 15, 2004; 24(22): 9695 - 9704.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Yamaguchi and H.-G. Wang
CHOP Is Involved in Endoplasmic Reticulum Stress-induced Apoptosis by Enhancing DR5 Expression in Human Carcinoma Cells
J. Biol. Chem., October 29, 2004; 279(44): 45495 - 45502.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Yamaguchi, J. Chen, K. Bhalla, and H.-G. Wang
Regulation of Bax Activation and Apoptotic Response to Microtubule-damaging Agents by p53 Transcription-dependent and -independent Pathways
J. Biol. Chem., September 17, 2004; 279(38): 39431 - 39437.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
U. De Marchi, S. Campello, I. Szabo, F. Tombola, J.-C. Martinou, and M. Zoratti
Bax Does Not Directly Participate in the Ca2+-induced Permeability Transition of Isolated Mitochondria
J. Biol. Chem., September 3, 2004; 279(36): 37415 - 37422.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. Arnoult, L. M. Bartle, A. Skaletskaya, D. Poncet, N. Zamzami, P. U. Park, J. Sharpe, R. J. Youle, and V. S. Goldmacher
Cytomegalovirus cell death suppressor vMIA blocks Bax- but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria
PNAS, May 25, 2004; 101(21): 7988 - 7993.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Poncet, N. Larochette, A.-L. Pauleau, P. Boya, A.-A. Jalil, P.-F. Cartron, F. Vallette, C. Schnebelen, L. M. Bartle, A. Skaletskaya, et al.
An Anti-apoptotic Viral Protein That Recruits Bax to Mitochondria
J. Biol. Chem., May 21, 2004; 279(21): 22605 - 22614.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Liu, Y. Ma, L. J. Pagliari, H. Perlman, C. Yu, A. Lin, and R. M. Pope
TNF-{alpha}-Induced Apoptosis of Macrophages Following Inhibition of NF-{kappa}B: A Central Role for Disruption of Mitochondria
J. Immunol., February 1, 2004; 172(3): 1907 - 1915.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
V. M. Dirsch, I. M. Muller, S. T. Eichhorst, G. R. Pettit, Y. Kamano, M. Inoue, J.-P. Xu, Y. Ichihara, G. Wanner, and A. M. Vollmar
Cephalostatin 1 Selectively Triggers the Release of Smac/DIABLO and Subsequent Apoptosis That Is Characterized by an Increased Density of the Mitochondrial Matrix
Cancer Res., December 15, 2003; 63(24): 8869 - 8876.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
J. M. Adams
Ways of dying: multiple pathways to apoptosis
Genes & Dev., October 15, 2003; 17(20): 2481 - 2495.
[Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
L. Fuino, P. Bali, S. Wittmann, S. Donapaty, F. Guo, H. Yamaguchi, H.-G. Wang, P. Atadja, and K. Bhalla
Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B
Mol. Cancer Ther., October 1, 2003; 2(10): 971 - 984.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamaguchi, H.
Right arrow Articles by Wang, H.-G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamaguchi, H.
Right arrow Articles by Wang, H.-G.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online